Aveed® Impact on GERD in Hypogonadal Males: 24-Month Cohort Study
Reading Time: < 1 minuteIntroduction Gastroesophageal reflux disease (GERD) affects approximately 20% of American adults, with a notable prevalence among males aged 40-65, often exacerbated by obesity, sedentary lifestyles, and hormonal imbalances. Hypogonadism, characterized by low serum testosterone levels, is increasingly recognized in U.S. men, impacting over 4 million individuals and correlating with gastrointestinal dysmotility. Aveed® (testosterone undecanoate), an extended-release intramuscular testosterone formulation by... Read more »
